Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Investigating Axonal Damage in Multiple Sclerosis by Diffusion Tensor Spectroscopy.
DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP).
Apitope Announces Completion of Enrolment in Phase IIA Clinical Trial of ATX-MS-1467 in Relapsing Multiple Sclerosis
Sodium accumulation is associated with disability and a progressive course in multiple sclerosis.
American Academy of Neurology Annual Meeting
Bridging the Brain Disease Knowledge Gap Through Computational Modeling and Systems Biology
A controlled trial of natalizumab for relapsing multiple sclerosis.
Patient page. Multiple sclerosis and vitamin D.
Death receptor 6 negatively regulates oligodendrocyte survival, maturation and myelination.
Delayed onset adenosine deaminase deficiency associated with acute disseminated encephalomyelitis.
Sensitivity and specificity of SWI venography for detection of cerebral venous alterations in multiple sclerosis.
Comprehending the inexplicable: qualitative accounts of black Caribbean and white british people severely affected by multiple sclerosis.
Pharmacological protection of CNS white matter during anoxia: actions of phenytoin, carbamazepine and diazepam.
The mammalian Na+/H+ exchanger gene family--initial structure/function studies.
The NOX1/4 Inhibitor GKT136901 as Selective and Direct Scavenger of Peroxynitrite.
FDA approves Ampyra to improve walking in adults with multiple sclerosis
Neuronal NF-κB ablation does not influence neuro-axonal degeneration in experimental autoimmune demyelination.
Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation.
Energy Cost of Walking and Its Association With Gait Parameters, Daily Activity, and Fatigue in Persons With Mild Multiple Sclerosis.
Effects of dalfampridine on multi-dimensional aspects of gait and dexterity in multiple sclerosis among timed walk responders and non-responders.
Improved self-efficacy in persons with relapsing remitting multiple sclerosis after an intensive social cognitive wellness program with participation of support partners: a 6-months observational study.
MRI in Leber's hereditary optic neuropathy: the relationship to multiple sclerosis.
Varicella-zoster virus acute myelitis in a patient with MS treated with natalizumab.
The risk of multiple sclerosis in bereaved parents: A nationwide cohort study in Denmark.
Food and Drug Administration briefing document for ofatumumab
Pages
« first
‹ previous
…
152
153
154
155
156
157
158
159
160
…
next ›
last »